David Gordon to Bacterial Vaccines
This is a "connection" page, showing publications David Gordon has written about Bacterial Vaccines.
Connection Strength
0.171
-
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial. Lancet Infect Dis. 2021 02; 21(2):252-262.
Score: 0.171